Compare SCLX & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | BEEM |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.2M | 28.6M |
| IPO Year | 2020 | 2018 |
| Metric | SCLX | BEEM |
|---|---|---|
| Price | $4.90 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 36.4K | ★ 1.5M |
| Earning Date | 04-10-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 40.77 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,253,000.00 | $28,236,000.00 |
| Revenue This Year | $122.52 | $40.48 |
| Revenue Next Year | $186.30 | $32.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.20 | $0.97 |
| 52 Week High | $34.27 | $4.04 |
| Indicator | SCLX | BEEM |
|---|---|---|
| Relative Strength Index (RSI) | 27.24 | 52.09 |
| Support Level | $4.20 | $1.36 |
| Resistance Level | $7.77 | $1.67 |
| Average True Range (ATR) | 0.30 | 0.10 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 5.93 | 11.90 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.